Lexicon Pharmaceuticals (LXRX) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free LXRX Stock Alerts $1.69 +0.07 (+4.32%) (As of 04:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lexicon Pharmaceuticals Short Interest DataCurrent Short Interest23,270,000 sharesPrevious Short Interest23,440,000 sharesChange Vs. Previous Month-0.73%Dollar Volume Sold Short$45.14 millionShort Interest Ratio6.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares246,240,000 sharesPercentage of Shares Shorted9.45%Today's Trading Volume2,787,559 sharesAverage Trading Volume4,015,589 sharesToday's Volume Vs. Average69% Short Selling Lexicon Pharmaceuticals ? Sign up to receive the latest short interest report for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLXRX Short Interest Over TimeLXRX Days to Cover Over TimeLXRX Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Lexicon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202423,270,000 shares $45.14 million -0.7%N/A6.3 $1.94 4/30/202423,440,000 shares $36.10 million +16.5%N/A5.3 $1.54 4/15/202420,120,000 shares $37.62 million -8.2%N/A4.2 $1.87 3/31/202421,910,000 shares $52.58 million +2.6%N/A4.7 $2.40 3/15/202421,350,000 shares $55.51 million +1.3%N/A4.6 $2.60 2/29/202421,070,000 shares $52.46 million -10.0%N/A4.9 $2.49 Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202423,410,000 shares $83.81 million +1.7%N/A6.4 $3.58 1/31/202423,030,000 shares $43.07 million -8.9%N/A8 $1.87 1/15/202425,270,000 shares $34.62 million +8.8%N/A10.3 $1.37 12/31/202323,220,000 shares $35.53 million -0.3%N/A8.6 $1.53 12/15/202323,280,000 shares $29.57 million -0.5%N/A9.1 $1.27 11/30/202323,400,000 shares $24.80 million +4.6%N/A9.3 $1.06 11/15/202322,370,000 shares $25.50 million +1.8%N/A9.3 $1.14 10/31/202321,980,000 shares $27.26 million +12.7%N/A9.9 $1.24 10/15/202319,500,000 shares $23.21 million -3.7%N/A9.1 $1.19 9/30/202320,240,000 shares $22.06 million +7.1%N/A11.2 $1.09 9/15/202318,900,000 shares $26.46 million +6.1%N/A11.5 $1.40 8/31/202317,810,000 shares $30.63 million +1.5%N/A9.5 $1.72 8/15/202317,550,000 shares $28.61 million -2.2%N/A6.6 $1.63 7/31/202317,950,000 shares $36.08 million +14.2%N/A6.9 $2.01 7/15/202315,720,000 shares $34.74 million +8.7%N/A6.3 $2.21 6/30/202314,460,000 shares $33.11 million +38.0%N/A6.1 $2.29 6/15/202310,480,000 shares $26.93 million -2.6%N/A4.9 $2.57 5/31/202310,760,000 shares $35.51 million +66.8%N/A6.3 $3.30 5/15/20236,450,000 shares $19.22 million +30.8%N/A8.5 $2.98 4/30/20234,930,000 shares $11.78 million +17.4%N/A8.1 $2.39 4/15/20234,200,000 shares $10.12 million +3.5%N/A9.5 $2.41 3/31/20234,060,000 shares $9.87 million +2.3%N/A10.3 $2.43 3/15/20233,970,000 shares $9.09 million +4.2%N/A9.3 $2.29 2/28/20233,810,000 shares $8.57 million -8.0%N/A9.3 $2.25 2/15/20234,140,000 shares $9.44 million +3.5%N/A11.3 $2.28 1/31/20234,000,000 shares $8.96 million +2.6%N/A10.6 $2.24 1/15/20233,900,000 shares $9.20 million +0.3%N/A9.8 $2.36 12/30/20223,890,000 shares $7.43 million +2.9%N/A9.3 $1.91 12/15/20223,780,000 shares $8.05 million +0.3%N/A8.6 $2.13 11/30/20223,770,000 shares $8.07 million -2.3%N/A7.8 $2.14 11/15/20223,860,000 shares $8.96 million -9.4%N/A7.5 $2.32 10/31/20224,260,000 shares $9.16 million -4.7%N/A6.4 $2.15 10/15/20224,470,000 shares $9.43 million -0.2%N/A4.4 $2.11 9/30/20224,480,000 shares $10.75 million +11.4%N/A4.3 $2.40Three basic steps to building the Ultimate Dividend Portfolio. (Ad)There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). 9/15/20224,020,000 shares $10.77 million +7.8%N/A2.4 $2.68 8/31/20223,730,000 shares $10.26 million +1.9%N/A2.2 $2.75 8/15/20223,660,000 shares $12.55 million -55.2%N/A2.2 $3.43 7/31/20228,170,000 shares $19.44 million -0.9%N/A5.3 $2.38 7/15/20228,240,000 shares $25.38 million +6.6%8.0%6.9 $3.08 6/30/20227,730,000 shares $14.38 million +34.4%7.5%6.6 $1.86 6/15/20225,750,000 shares $8.05 million +5.7%5.6%10.5 $1.40 5/31/20225,440,000 shares $9.63 million +1.3%N/A10.9 $1.77 5/15/20225,370,000 shares $9.29 million +0.9%N/A8.8 $1.73 4/30/20225,320,000 shares $9.63 million +11.5%N/A8.4 $1.81 4/15/20224,770,000 shares $11.11 million +2.8%N/A7.3 $2.33 3/31/20224,640,000 shares $9.70 million -2.1%N/A7.1 $2.09 3/15/20224,740,000 shares $9.24 million -2.1%N/A6.8 $1.95 2/28/20224,840,000 shares $10.02 million +8.3%N/A6.8 $2.07 2/15/20224,470,000 shares $13.50 million +17.6%N/A7 $3.02 1/31/20223,800,000 shares $12.05 million +5.3%N/A5.9 $3.17 1/15/20223,610,000 shares $12.45 million +1.4%N/A5.6 $3.45 12/31/20213,560,000 shares $14.03 million +10.9%N/A5 $3.94 12/15/20213,210,000 shares $12.78 million -10.6%N/A4.3 $3.98 11/30/20213,590,000 shares $16.44 million -0.6%N/A4.9 $4.58 11/15/20213,610,000 shares $18.59 million +8.4%N/A4.1 $5.15 10/29/20213,330,000 shares $17.62 million -2.4%2.4%3.5 $5.29 10/15/20213,410,000 shares $21.01 million -2.9%2.4%3.6 $6.16 9/30/20213,510,000 shares $16.88 million -4.6%2.5%3.8 $4.81 9/15/20213,680,000 shares $16.71 million -11.1%2.6%3.4 $4.54 8/31/20214,140,000 shares $19.54 million +16.6%3.0%4 $4.72 8/13/20213,550,000 shares $12.89 million -8.5%2.5%4 $3.63 7/30/20213,880,000 shares $13.74 million -3.2%2.8%4.7 $3.54 7/15/20214,010,000 shares $14.80 million -8.2%2.9%4.9 $3.69 6/30/20214,370,000 shares $20.06 million +24.2%3.1%5.2 $4.59 6/15/20213,520,000 shares $16.68 million -3.3%2.5%5.3 $4.74 5/28/20213,640,000 shares $15.98 million -9.0%2.6%4.7 $4.39 5/14/20214,000,000 shares $16.80 million -5.7%N/A4.5 $4.20 4/30/20214,240,000 shares $21.37 million -5.4%N/A3.9 $5.04 4/15/20214,480,000 shares $23.25 million +20.1%N/A2.9 $5.19 3/31/20213,730,000 shares $21.15 million -24.0%N/A0.8 $5.67 3/15/20214,910,000 shares $33.73 million +36.8%N/A0.9 $6.87 2/26/20213,590,000 shares $26.85 million -20.0%N/A0.4 $7.48 2/12/20214,490,000 shares $35.96 million -16.2%N/A0.5 $8.01 1/29/20215,360,000 shares $43.20 million -52.9%N/A0.5 $8.06 1/15/202111,380,000 shares $91.61 million -5.1%N/A1 $8.05 12/31/202011,990,000 shares $39.69 million -2.0%N/A1.6 $3.31 12/15/202012,240,000 shares $36.48 million +29.0%N/A1.7 $2.98 11/30/20209,490,000 shares $15.37 million -1.7%N/A1.6 $1.62 11/15/20209,650,000 shares $12.26 million -0.4%N/A3.7 $1.27 10/30/20209,690,000 shares $11.24 million +3.1%N/A11.7 $1.16 10/15/20209,400,000 shares $13.63 million -7.2%9.1%7.7 $1.45 9/30/202010,130,000 shares $14.59 million -14.4%9.8%5.9 $1.44 9/15/202011,830,000 shares $18.81 million -13.0%11.5%7.1 $1.59 8/31/202013,590,000 shares $23.78 million -9.4%13.2%7.9 $1.75WARNING about the death of the U.S. dollar… (Ad)Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)Get Colonial Metals' new Precious Metals Investment Guide. 8/14/202015,000,000 shares $27.15 million -8.9%14.5%8.6 $1.81 7/31/202016,460,000 shares $31.93 million +44.8%15.9%9.5 $1.94 7/15/202011,370,000 shares $22.29 million +9.3%11.0%8.2 $1.96 6/30/202010,400,000 shares $20.59 million -4.8%10.1%11.3 $1.98 6/15/202010,920,000 shares $20.64 million +8.6%10.6%11.7 $1.89 5/29/202010,060,000 shares $19.21 million -3.5%9.8%10.4 $1.91 5/15/202010,420,000 shares $19.59 million -0.7%10.1%10.8 $1.88 4/30/202010,490,000 shares $19.83 million -0.3%10.2%10.8 $1.89 4/15/202010,520,000 shares $21.25 million -5.9%10.2%11.1 $2.02 3/31/202011,180,000 shares $22.92 million -25.4%10.8%11.6 $2.05 3/13/202014,991,800 shares $28.18 million -9.5%14.6%14.5 $1.88 2/28/202016,570,000 shares $33.80 million +2.7%16.2%14.3 $2.04 2/14/202016,130,000 shares $37.10 million +3.2%15.7%12.7 $2.30 1/31/202015,630,000 shares $44.70 million +7.6%15.2%11.7 $2.86 1/15/202014,520,000 shares $46.75 million +6.9%14.1%10.5 $3.22 12/31/201913,580,000 shares $45.63 million +17.8%13.2%9.9 $3.36 8/15/20197,668,900 shares $10.20 million -17.4%7.5%7.1 $1.33 LXRX Short Interest - Frequently Asked Questions What is Lexicon Pharmaceuticals' current short interest? Short interest is the volume of Lexicon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 23,440,000 shares of LXRX short. Learn More on Lexicon Pharmaceuticals' current short interest. What is a good short interest ratio for Lexicon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LXRX shares currently have a short interest ratio of 5.0. Learn More on Lexicon Pharmaceuticals's short interest ratio. Is Lexicon Pharmaceuticals' short interest increasing or decreasing? Lexicon Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 23,440,000 shares, an increase of 16.5% from the previous total of 20,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lexicon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lexicon Pharmaceuticals: Verastem, Inc. (3.49%), Vanda Pharmaceuticals Inc. (4.17%), XOMA Co. (2.33%), Emergent BioSolutions Inc. (14.13%), Rigel Pharmaceuticals, Inc. (3.23%), Regulus Therapeutics Inc. (7.33%), Rezolute, Inc. (0.78%), OPKO Health, Inc. (26.42%), Innoviva, Inc. (18.39%), Ironwood Pharmaceuticals, Inc. (13.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lexicon Pharmaceuticals stock? Short selling LXRX is an investing strategy that aims to generate trading profit from Lexicon Pharmaceuticals as its price is falling. LXRX shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexicon Pharmaceuticals? A short squeeze for Lexicon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LXRX, which in turn drives the price of the stock up even further. How often is Lexicon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LXRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VSTM Short Interest Data VNDA Short Interest Data XOMA Short Interest Data EBS Short Interest Data RIGL Short Interest Data RGLS Short Interest Data RZLT Short Interest Data OPK Short Interest Data INVA Short Interest Data IRWD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LXRX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDigitizing the $11T commodities sector with one tiny stockResource Stock DigestThe only AI company to buyPorter & CompanyBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsIs Artificial Intelligence the Biggest Bubble in History?InvestorPlacePresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.